Legal & General Group Plc - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 73 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q3 2014. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q2 2019$3,000
-66.7%
6,8440.0%0.00%
Q1 2019$9,000
+12.5%
6,8440.0%0.00%
Q4 2018$8,000
-57.9%
6,8440.0%0.00%
Q3 2018$19,000
-20.8%
6,8440.0%0.00%
Q2 2018$24,000
-17.2%
6,844
-28.6%
0.00%
Q1 2018$29,000
-64.6%
9,586
-26.7%
0.00%
Q4 2017$82,000
-16.3%
13,077
-8.9%
0.00%
Q3 2017$98,000
+30.7%
14,360
+44.2%
0.00%
Q2 2017$75,000
-18.5%
9,9580.0%0.00%
Q1 2017$92,000
+80.4%
9,958
-19.0%
0.00%
Q4 2016$51,000
+142.9%
12,301
+125.0%
0.00%
Q3 2016$21,000
-27.6%
5,467
-19.1%
0.00%
Q2 2016$29,000
-3.3%
6,7560.0%0.00%
Q1 2016$30,000
-55.9%
6,7560.0%0.00%
Q4 2015$68,000
+33.3%
6,7560.0%0.00%
Q3 2015$51,000
-79.0%
6,756
+23.6%
0.00%
Q2 2015$243,000
+64.2%
5,467
+37.0%
0.00%
Q1 2015$148,000
-9.2%
3,9910.0%0.00%
Q4 2014$163,000
+87.4%
3,991
-7.8%
0.00%
Q3 2014$87,0004,3280.00%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q3 2014
NameSharesValueWeighting ↓
Rhenman & Partners Asset Management AB 300,000$1,209,0000.23%
Rock Springs Capital Management LP 698,000$2,813,0000.19%
Eventide Asset Management 600,000$2,418,0000.16%
Teza Capital Management LLC 14,369$58,0000.08%
Candriam S.C.A. 374,000$1,507,0000.04%
R&F Capital Advisors LP 23,778$96,0000.03%
Tekla Capital Management LLC 192,322$775,0000.03%
Sunbelt Securities, Inc. 6,000$24,180,0000.03%
DOW CHEMICAL CO /DE/ 65,000$249,0000.03%
CANADA PENSION PLAN INVESTMENT BOARD 1,654,100$6,666,0000.02%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders